Molecular thanatopsis: A discourse on the BCL2 family and cell death

Blood

Volumn 88, Issue 2, 1996, Pages 386-401

  Yang, Elizabeth ^a   Korsmeyer, Stanley J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTIMETABOLITE; CALCIUM; GLUCOCORTICOID; INTERLEUKIN 2; INTERLEUKIN 3; PHORBOL ESTER; STAUROSPORINE;

CELL DEATH; CELL SURVIVAL; CHROMOSOME 18Q; FOLLICULAR LYMPHOMA; GENE MUTATION; ONCOGENE; PRIORITY JOURNAL; REVIEW;

EID: 0029899181     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.2.386.bloodjournal882386     Document Type: Review

References (150)

1. Fukuhara S, Rowley JD, Variakojis D, Golomb HM: Chromosome abnormablities in poorly differentiated lymphocytic lymphoma. Cancer Res 39:3119, 1979
2. Yunis JJ, Frizzera G, Oken MM, McKenna J, Theologides A, Arnesen M: Multiple recurrent genomic defects in follicular lymphoma. N Engl J Med 316:79, 1987
3. Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM: The t(14; 18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229:1390, 1985
4. H on chromosome 14 and near a transcriptional unit on 18. Cell 41:889, 1985
5. Cleary ML, Sklar J: Nucleotide sequence of a t(14; 18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 82:7439, 1985
6. Cleary ML, Smith SD, Sklar J: Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14; 18) translocation. Cell 47:19, 1986
7. Vaux DL, Cory S, Adams JM: Bcl-2 oncogene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440, 1988
8. Nunez G, London L, Hockenbery D, Alexander M, McKearn J, Korsmeyer SJ: Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602, 1990
9. Korsmeyer SJ: Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80:879, 1992
10. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334, 1990
11. Deng G, Podack ER: Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2. Proc Natl Acad Sci USA 90:2189, 1993
12. L Cancer Res 55:2262, 1995
13. Sentman DL, Shutter JR, Hockenbery D. Kanagawa O, Korsmeyer SJ: Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879, 1991
14. Strasser A, Harris AW, Cory S: Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889, 1991
15. McDonnell TJ, Deanne N, Platt FM, Nunez G, Jaeger U, McKearn JP, Korsmeyer SJ: Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57:79, 1989
16. McDonnell TJ, Korsmeyer SJ: Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature 349:6306, 1991
17. μ-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells. Oncogene 8:1, 1993
18. Marin MC, Hsu B, Stephens LC, Brisbay S, McDonnell TJ: The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo. Exp Cell Res 217:240, 1995
19. pr-bcl-2 transgenic mice. Blood 86:1255, 1995
20. Batistatou A, Merry DE, Korsmeyer SJ, Green LA: Expression of Bcl-2 proto-oncogene rescues PC12 cells from death caused by withdrawal of trophic support. J Neurosci 13:4422, 1993
21. Mah SP, Zhong LT, Liu Y, Roghani A, Edwards RH, Bredesen DE: The protooncogene bcl-2 inhibits apoptosis in PC12 cells. J Neurochem 60:1183, 1993
22. Garcia I, Martinou I, Tsujimoto Y, Martinou J-C: Prevention of programmed cell death of sympathetic neurons by the bcl-2 protooncogene. Science 258:302, 1992
23. Allsopp TE, Wyatt S, Paterson HF, Davies AM: The protooncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 73:295, 1993
24. Zhong LT, Sarafian T, Kane DJ, Charles AC, Mah SP, Edwards RH, Bredesen DE: bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA 90:4533, 1993
25. Martinou J-C, Dubois-Dauphin M, Staple JK, Rodriguez I, Frankowski H, Missotten M, Albertini P, Talabot D, Catsicas S, Pietra C, Huarte J: Overexpression of BCL2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13:1017, 1994
26. Dubois-Dauphin M, Frankowski H, Tsujimoto Y, Huarte J, Martinou J-C: Neonatal motoneurons overexpressing the bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death. Proc Natl Acad Sci USA 91:3309, 1994
27. Greenlund LJS, Korsmeyer SJ, Johnson EM: Role of bcl-2 in the survival and function of developing and mature sympathetic neurons. Neuron 15:647, 1995
28. Rao L, Debbas M, Sabbatini P, Hockenbery D, Korsmeyer S, White E: The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19kDa and Bcl-2 proteins. Proc Natl Acad Sci USA 89:7742, 1992
29. Debbas M, White E: Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev 7:546, 1993
30. Chiou S-K, Tseng C-C, Rao L, White E: Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J Virol 68:6553, 1994
31. Chiou S-K, Rao L, White E: Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol 14:2556, 1994
32. Yamada T, Yamaoka S, Goto T, Nakai M, Tsujimoto Y, Hatanaka M: The human T-cell leukemia virus type I Tax protein induces apoptosis which is blocked by the Bcl-2 protein. J Virol 68:3374, 1994
33. Levine B, Huang Q, Isaacs JT, Reed JC, Griffin DE, Hardwick M: Conversion of lytic to persistent alphavirus infection by the bcl2 cellular oncogene. Nature 361:739, 1993
34. Newmeyer DD, Farschon DM, Reed JC: Cell-free apoptosis in Xenopus egg extracts: Inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell 79:353, 1994
35. Selvakumaran M, Lin HK, Sjin RT, Reed JC, Liebermann DA, Hoffman B: The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor β1-induced apoptosis of myeloid leukemia cells. Mol Cell Biol 14:2352, 1994
36. Selvakumaran M, Lin HK, Miyashita T, Wang HG, Krajewski S, Reed JC, Hoffman B, Liebermann D: Immediate early up-regulation of bax expression by p53 but not TGFβ1: A paradigm for distinct apoptotic pathways. Oncogene 9:1791, 1994
37. Miyashita T, Reed JC: Bcl-2 gene transfer increases relative resistance of S49.1 and WEH17.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res 52:5407, 1992
38. Desoize B: Anticancer drug resistance and inhibition of apoptosis. Anticancer Res 14:2291, 1994
39. Lowe SW, Ruley HE, Jacks T, Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957, 1993
40. Walton MI, Whysong D, O'Connor PM, Hockenbery D, Korsmeyer SJ, Kohn KW: Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Res 53:1853, 1993
41. Fisher TC, Milner AE, Gregory CD, Jackman AL, Aherne W, Hartley JA, Dive C, Hickman JA: bcl-2 modulation of apoptosis induced by anticancer drugs: Resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res 53:3321, 1993
42. Reed JC, Kitada S, Takayama S, Miyashita T: Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cell lines. Ann Oncol 5:S61, 1994
43. Miyashita T, Reed JC: Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81:151, 1993
44. Reed JC, Kitada S, Takayama S, Miyashita T: Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cell lines. Ann Oncol 5:S61, 1994
45. Vaux DL, Aguila HL, Weissman IL: Bcl-2 prevents death of factor-deprived cells but fails to prevent apoptosis in targets of cell mediated killing. Int Immunol 4:821, 1992
46. Chen-Levy Z, Nourse J, Cleary ML: The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14; 18) translocation. Mol Cell Biol 9:701, 1989
47. Monaghan P, Robertson D, Amos T, Dyer M, Mason D, Greaves M: Ultrastructural localization of Bcl-2 protein. J Histochem Cytochem 40:1819, 1992
48. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC: Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 53:4701, 1993
49. de Jong D, Prins FA, Mason DY, Reed JC, van Ommen GN, Kluin PM: Subcellular localization of the bcl-2 protein in malignant and normal lymphoid cells. Cancer Res 54:256, 1994
50. Nguyen M, Millar DG, Yong VW, Korsmeyer SJ, Shore GC: Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. J Biol Chem 268:25265, 1993
51. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241, 1993
52. Nguyen M, Branton PE, Walton PA, Oltvai ZN, Korsmeyer SJ, Shore GC: Role of membrane anchor domain of Bcl-2 in suppression of apoptosis caused by E1B-defective adenovirus. J Biol Chem 269:16521, 1994
53. Tanaka S, Saito K, Reed JC: Structure-function analysis of the Bcl-2 oncoprotein. Addition of a heterologous transmembrane domain to portions of the Bcl-2β protein restores function as a regulator of cell survival. J Biol Chem 268:10921, 1993
54. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC: Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361:365, 1993
55. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T, Bredesen DE: Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science 262:1274, 1993
56. L. Nature 372:811, 1995
57. Jacobson MD, Raff MC: Programmed cell death and Bcl-2 protection in very low oxygen. Nature 374:814, 1995
58. Lam M, Dubyak G, Distelhorst CW: Effect of glucocorticosteroid treatment on intracellular calcium homeostasis in mouse lymphoma cells. Mol Endocrinol 5:686, 1993
59. 2+ fluxes. Proc Natl Acad Sci USA 91:6569, 1994
60. Baffy G, Miyashita T, Williamson JR, Reed JC: Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J Biol Chem 268:6511, 1993
61. Oltvai ZN, Milliman CL, Korsmeyer: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609, 1993
62. Yin X-M, Oltvai ZN, Korsmeyer SJ: BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369:321, 1994
63. Krajewski S, Krajewski M, Shabaik A, Miyashita T, Wang HG, Reed JC: Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 145:1323, 1994
64. Veis DJ, Sentman CL, Back EA, Korsmeyer SJ: Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes. J Immunol 151:2546, 1993
65. Gratiot-Deans J, Ding L, Turka LA, Nunez G: Bcl-2 protooncogene expression during human T cell development. J Immunol 151:83, 1993
66. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597, 1993
67. Fang W, Rivard JJ, Mueller DL, Behrens TW: Cloning and molecular characterization of mouse bcl-x in B and T lymphocytes. J Immunol 153:4388, 1994
68. L and Bcl-2 repress a common pathway of cell death. J Exp Med 182:821, 1995
69. Linette GP, Brusby MJ, Hedrick SM, Hansen TH, Glimcher LH, Korsmeyer SJ: Bcl-2 is upregulated at the CD4+CD8+ stage during positive selection and promotes thymocyte differentiation at several control points. Immunity 1:197, 1994
70. Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, Thompson CB, Korsmeyer SJ: Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc Natl Acad Sci USA 92:7834, 1995
71. L is the major bd-x mRNA form expressed during murine development and its product localizes to mitochondria. Development 120:3033, 1994
72. Gottschalk AR, Boise LH, Thompson CB, Quintans J: Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2. Proc Natl Acad Sci USA 91:7350, 1994
73. L. Immunity 3:87, 1995
74. Ma A, Pena JC, Chang B, Margosian E, Davidson L, Alt RW, Thompson CB: Bcl-x regulates the survival of double positive thymocytes. Proc Natl Acad Sci USA 92:4763, 1995
75. Krajewski S, Krajewska M, Shabaik A, Wang H-G, Irie S, Fong L, Reed JC: Immunohistochemical analysis of in vivo patterns of Bcl-x expression. Cancer Res 54:5501, 1994
76. Motoyama N, Wang F, Roth KA, Sawa H, Nakayama K-i, Nakayama K, Negishi I, Senju S, Zhang Q, Fujii S, Loh DY: Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267:1506, 1995
77. Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW: MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc Natl Acad Sci USA 90:3516, 1993
78. Lin EY, Orlofsky A, Berger MS, Prystowsky MB: Characterization of Al, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J Immunol 151:1979, 1993
79. Sato T, Hanada M, Bodrug S, Irie S, Iwama N, Boise LH, Thompson CB, Golemis E, Fong L, Wang H-G, Reed JC: Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA 91:9238, 1994
80. Bodrug SE, Aime-Sempe C, Sato T, Krajewski S, Hanada M, Reed JC: Biochemical and functional comparisons of Mcl-1 and Bcl-2 proteins: Evidence for a novel mechanism of regulating Bcl-2 family protein function. Cell Death Differ 2:173, 1995
81. Reynolds JE, Yang T, Qian L, Jenkinson JD, Zhou P, Eastman A, Craig RW: Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. Cancer Res 64:6348, 1994
82. Farrow SN, White JHM, Martinou I, Raven T, Pun K-T, Grinham CJ, Martinou J-C, Brown R: Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 374:731, 1995
83. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, Guild BC: Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374:733, 1995
84. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD, Barr PJ: Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 374:736, 1995
85. Pearson GR, Luka J, Petti L, Sample J, Blrkenback M, Braun D, Kieff E: Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology 160:151, 1987
86. Smith CA: A novel viral homologue of Bcl-2 and Ced-9. Trends Cell Biol 5:344, 1995
87. Neilan JG, Lu Z, Afonso CL, Kutish GF, Sussman MD, Rock DL: An African swine fever virus gene with similarity to the protooncogene bcl-2 and the Epstein-Barr virus gene BHRF1. J Virol 67:4391, 1993
88. L and Bcl-2, displaces Bax and promotes cell death. Cell 80:285, 1995
89. Takayama S, Sato T, Krajewski S, Kockel K, Irie S, Millan JA, Reed JC: Cloning and functional analysis of BAG-1: A novel Bcl-2 binding protein with anti-cell death activity. Cell 80:279, 1995
90. Hengartner MO, Horvitz HR: Programmed cell death in Caenorhabditis elegans. Curr Opin Genet Dev 4:581, 1994
91. Hengartner MO, Horvitz HR: The ins and outs of programmed cell death during C. elegans development. Phil Trans R Soc Lond B 345:243, 1994
92. Hengartner MO, Horvitz HR: Activation of C. elegans cell death protein CED-9 by an amino-acid substitution in a domain conserved in Bcl-2. Nature 369:318, 1994
93. Hengartner MO, Ellis RE, Horvitz HR: Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 356:494, 1992
94. Hengartner MO, Horvitz HR: C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 76:665, 1994
95. Vaux DL, Weissman IL, Kim SK: Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science 258:1955, 1992
96. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR: The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 75:641, 1993
97. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J: Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75:653, 1993
98. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, McDowell J, Paskind M, Rodman L, Salfeld J, Towne E, Tracey D, Wardwell S, Wei F-Y, Wong W, Kamen R, Seshadri T: Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80:401, 1995
99. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su M S-S, Flavell RA: Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267:2000, 1995
100. Enari M, Hug H, Nagata S: Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375:78, 1995
101. Los M, Van de Craen M, Penning LC, Schenk H, Westendorp M, Baeuerle PA, Droge W, Krammer PH, Fiers W, Schulze-Ostholl K: Requirement of an ICE-CED-3 protease for Fas/APO-1 mediated apoptosis. Nature 375:81, 1995
102. Kumar S, Kinoshita M, Noda M, Copeland NG, Jenkins NA: Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1β-converting enzyme. Genes Dev 8:1613, 1994
103. Wang L, Miura M, Bergeron L, Zhu H, Yuan J: Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78:739, 1994
104. Fernandes-Alnemri T, Litwack G, Alnemri E: CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein ced-3 and mammalian interleukin-1β-converting enzyme. J Biol Chem 269:30761, 1994
105. Tewari M, Quan LT, O'Rourke, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM: Yama/CPP32β, a mammalian homolog of CED-3, is a crmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81:801, 1995
106. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T-T, Yu VL, Miller DK: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37, 1995
107. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC: Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371:346, 1994
108. Steller H: Mechanisms and genes of cellular suicide. Science 267:1445, 1995
109. Merry DE, Veis DJ, Hickey WF, Korsmeyer SJ: bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 120:301, 1994
110. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ: Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229, 1993
111. Nakayama K, Nakayama K-I, Negishi I, Kuida K, Sawa H, Loh DY: Targeted disruption of Bcl-2 αβ in mice: Occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc Natl Acad Sci USA 91:3700, 1994
112. Kamada S, Shimono A, Shinto Y, Tsujimura T, Takahashi T, Noda T, Kitamura Y, Kondoh H, Tsujimoto Y: bcl-2 deficiency in mice leads to pleiotropic abnormalities: Accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine. Cancer Res 55:354, 1995
113. LeBrun DP, Warnke RA, Cleary ML: Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 142:743, 1993
114. Sorenson CM, Rogers SA, Korsmeyer SJ, Hammerman MR: Fulminant metanephric apoptosis and abnormal kidney development in bcl-2-deficient mice. Am J Physiol 268:F73, 1995
115. Motoyama N, Wang F, Roth KA, Sawa H, Nakayama K-i, Nakayama K, Negishi I, Senju S, Zhang Q, Fujii S, Loh DY: Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267:1506, 1995
116. Strasser A, Harris AW, Bath ML, Cory S: Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348:331, 1990
117. Bissonnette RP, Echeverri F, Mahboubi A, Green DR: Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359:552, 1992
118. Evans G, Wyllie A, Gilbert C, Littlewood T, Land H, Brooks M, Waters C, Penn L, Hancock D: Induction of apoptosis in fibroblasts by c-myc protein. Cell 63:119, 1992
119. Fanidi A, Harrington EA, Evan GI: Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359:554, 1992
120. Harrington EA, Bennett MR, Fanidi A, Evan GI: c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 13:3286, 1994
121. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847, 1993
122. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849, 1993
123. Fisher DE: Apoptosis in cancer therapy: Crossing the threshold. Cell 78:539, 1994
124. Strasser A, Harris AW, Jacks T, Cory S: DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 79:329, 1994
125. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC: Tumor suppressor p53 is regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799, 1994
126. Zhan Q, Fan S, Bae I, Buillouf C, Liebermann DA, O'Connor PM, Fornace AJ Jr: Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene 9:3743, 1994
127. Knudson CM, Tung KSK, Tourtellotte WG, Brown GAJ, Korsmeyer SJ: Sax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270:96, 1995
128. Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, Jacks T, Van Dyke T: p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78:703, 1994
129. Yunis JJ, Mayer MG, Arnesen MA, Aeppli DP, Oken M, Frizzera G: Bcl-2 and other genomic alteration in the prognosis of large-cell lymphoma. N Engl J Med 320:1047, 1989
130. Levine EG, Arthur DC, Frizzera G, Peterson BA, Hurd DD, Bloomfield CD: Cytogenetic abnormalities predict clinical outcome in non-Hodgkin's lymphoma. Ann Intern Med 108:14, 1988
131. Pezzela F, Jones M, Ralfkiaer E, Ersboll J, Gatter KC, Mason DY: Evaluation of bcl-2 protein expression and 14; 18 translocation as prognostic markers in follicular lymphoma. Br J Cancer 65:87, 1992
132. Tilly H, Rossi A, Stamatoullas A, Lenormand B, Bigorgne C, Kunlin A, Monconduit M, Bastard C: Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 84:1043, 1994
133. Akagi T, Kondo E, Yoshino T: Expression of Bcl-2 protein and Bcl-2 mRNA in normal and neoplastic lymphoid tissues. Leuk Lymphoma 13:81, 1994
134. Zutter M, Hockenbery D, Silverman GA, Korsmeyer SJ: Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms. Blood 78:1062, 1991
135. H rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 6:2271, 1991
136. Aster JC, Kobayashi Y, Shiota M, Mori S, Sklar J: Detection of t(14; 18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients. Am J Pathol 141:291, 1992
137. Limpens J, Stad R, Vos C, de Vlaam C, de Jong D, van Ommen GJ, Schuuring E, Kluin PM: Lymphoma-associated translocation t(14; 18) in blood B cells of normal individuals. Blood 85:2528, 1995
138. Liu Y, Hernandez AM, Shibata D, Cortopossi GA: BCL2 translocation frequency rises with age in humans. Proc Natl Acad Sci USA 91:8910, 1994
139. Gribben J, Freedman A, Woo SD, Blake K, Shu RS, Freeman G, Longtine JA, Pinkus GS, Nadler LM: All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 78:3275, 1991
140. Price CGA, Meerabux J, Murtagh S, Cotter FE, Rohatiner AZS, Young BD, Lister TA: The significance of circulating cells carrying t(14; 18) in long remission from follicular lymphoma. J Clin Oncol 9:1527, 1991
141. Gribben JG, Neuberg D, Barber M, Moore J, Pesek KW, Freedman AS, Nadler LM: Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood 83:3800, 1994
142. Johnson PWM, Price CGA, Smith T, Cotter FE, Meerabux J, Rohatiner AZS, Young BD, Lister TA: Detection of cells bearing the t(14; 18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma. J Clin Oncol 12:798, 1994
143. Leek RD, Kaklamanis L, Pezzella F, Gatter KC, Harris AL: bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br J Cancer 69:135, 1994
144. Silvestrini R, Veneroni S, Daidone MG, Benini E, Boracchi P, Mezzetti M, DiFronzo G, Rilke F, Veronesi U: The Bcl-2 protein: A prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J Natl Cancer Inst 86:499, 1994
145. Sierra A, Lloveras B, Castellsague X, Moreno L, Garcia-Ramirez M, Fabra A: Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma. Int J Cancer 60:54, 1995
146. Colombel M, Symmans F, Gil S, O'Toole KM, Chopin D, Benson M, Olsson CA, Korsmeyer S, Buttyan R: Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am J Pathol 143:390, 1993
147. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LWK, Hsieh J-T, Tu S-M, Campbell ML: Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 52:6940, 1992
148. Campos L, Rouault J-P, Sabido O, Oriol P, Roubi N, Vasselon C, Archimbaud E, Magaud J-P, Guyotat D: High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 81:3091, 1993
149. Maung ZT, MacLean FR, Reid MM, Pearson ADJ, Proctor SJ, Hamilton PJ, Hall AG: The relationship between bcl-2 expression and response to chemotherapy in acute leukaemia. Br J Haematol 88:105, 1994
150. L by cytotoxic drug exposure confers resistance to ionizing radiation-induced internucleosomal DNA fragmentation. Cell Growth Differ 6:363, 1995